GSK-3 as potential target for therapeutic intervention in cancer-Reference-Cited by-同舟云学术

GSK-3 as potential target for therapeutic intervention in cancer

Published:2014-05-28 Issue:10 Volume:5 Page:2881-2911
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

McCubrey James A.¹,Steelman Linda S.¹,Bertrand Fred E.²,Davis Nicole M.¹,Sokolosky Melissa¹,Abrams Steve L.¹,Montalto Giuseppe³,D’Assoro Antonino B.⁴,Libra Massimo⁵,Nicoletti Ferdinando⁵,Maestro Roberta⁶,Basecke Jorg⁷⁸,Rakus Dariusz⁹,Gizak Agnieszka⁹,Demidenko Zoya¹⁰,Cocco Lucio¹¹,Martelli Alberto M.¹¹,Cervello Melchiorre¹²

Affiliation:

1. Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University Greenville, NC, USA

2. Department of Oncology, Brody School of Medicine at East Carolina University Greenville, NC, USA

3. Biomedical Department of Internal Medicine and Specialties, University of Palermo, Palermo, Italy

4. Department of Medical Oncology, Mayo Clinic Cancer Center, Rochester, MN, USA

5. Department of Bio-Medical Sciences, University of Catania, Catania, Italy

6. Experimental Oncology 1, CRO IRCCS, National Cancer Institute, Aviano, Pordenone, Italy

7. Department of Medicine, University of Göttingen, Göttingen, Germany

8. Sanct-Josef-Hospital Cloppenburg, Department of Hematology and Oncology, Cloppenburg, Germany

9. Department of Animal Molecular Physiology, Institute of Experimental Biology, Wroclaw University, Wroclaw, Poland

10. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA

11. Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy

12. Consiglio Nazionale delle Ricerche, Istituto di Biomedicina e Immunologia Molecolare “Alberto Monroy”, Palermo, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 391 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer;Cancer Drug Resistance;2024-01-31

2. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers;Clinical and Experimental Medicine;2024-01-31

3. mTORC3 activity is regulated by GSK3β through the activation of PKCδ that phosphorylates and activates STAT1;2024-01-27

4. Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model;International Journal of Molecular Sciences;2024-01-20

5. Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease;Molecular Neurobiology;2023-12-08